Atypical intraosseous osteolytic meningioma mimicking calvarial metastasis  by Cheng, Hsien-Tsung et al.
Formosan Journal of Surgery (2012) 45, 69e72Available online at www.sciencedirect.com
journal homepage: www.e-f js .comCASE REPORT
Atypical intraosseous osteolytic meningioma
mimicking calvarial metastasisHsien-Tsung Cheng a,d, Chin-Hong Chang a, Chung-Ching Chio a,
Sheng-Tsung Chang b, Yu-Lin Wang c,*aDepartment of Neurosurgery, Chi-Mei Medical Center, Tainan, Taiwan
bDepartment of Pathology, Chi-Mei Medical Center, Tainan, Taiwan
cDepartment of Rehabilitation, Chi-Mei Medical Center, Tainan, Taiwan
dDepartment of Neurosurgery, Kuo General Hospital, Tainan, Taiwan
Received 29 March 2011; received in revised form 26 May 2011; accepted 14 August 2011
Available online 9 March 2012KEYWORDS
intraosseous;
metastasis;
meningioma;
skull* Corresponding author. Departmen
Medical Center, 901 Chung Hwa Roa
710, Taiwan.
E-mail address: freey.a566@msa.h
1682-606X/$ - see front matter Copyr
doi:10.1016/j.fjs.2012.02.002Summary Meningiomas are common benign intracranial neoplasms. Among the subtypes of
the meningiomas, primary intraosseous meningiomas are the most uncommon. The authors
report a 68-year-old woman who has had headache, dizziness, and a progressively enlarged
mass in the forehead for 2 months. Computed tomography of the brain showed an osteolytic
skull lesion with brain and scalp invasion. A complete systemic survey for metastatic tumors
was negative. The patient underwent Simpson grade I tumor resection via the frontotemporal
approach, followed by cranioplasty with bone cement. The pathologic examination revealed
atypical meningioma. Postoperatively, she received adjuvant fractionated conformal brain
radiotherapy. The result was satisfactory. In this report, in addition to presenting the clinical
manifestation and treatment of the patient, the authors emphasize the importance of
considering atypical intraosseous meningioma in the differential diagnosis of osteolytic skull
tumors.
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If an elderly person has a bulgingmass on the head, a primary
bone tumor ormetastatic tumor is first considered.1 A review
of the literature shows that a meningioma originating in an
extradural locationpresenting as an intraosseousmass is very
rare.2 In most cases such a tumor is characterized byciation. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Computed tomography of the brain shows
a 5 5 cm osteolytic mass in the left frontotemporal area.
70 H.-T. Cheng et al.osteoblastic or mixed osteoblastic-osteolytic changes
without invading soft tissue.3 We report a rare case of an
atypical osteolytic intraosseous meningioma with scalp and
brain invasion in a 68- year-old woman.Figure 2 (A) A 5 5 cm protruding mass at the left frontal ar
consistency with skull erosion (arrow) and scalp invasion (arrowhe
removal of tumor. (D) Cranioplasty with bone cement after tumor2. Case report
A 68-year-old woman was brought to the emergency room
with the chief complaint of headache and dizziness, which
she had been experiencing for several weeks. Noncontrast
computed tomography (CT) of the head showed an
osteolytic mass (5 5 cm) in the left frontal area of the
head (Fig. 1). Under the impression of a metastatic tumor,
a series of studies was performed. Tumor marker values,
including those for cancer antigen 125 (CA-125; 14.7
U/mL), CA 15-3 (5.8 U/mL), CA 19-9 (13.4 U/mL), squa-
mous cell carcinoma antigen (SCC Ag; 0.3 ng/mL), alpha-
fetoprotein (AFP; 5.9 ng/mL), and carcinoembryonic
antigen (CEA; 2.4 ng/mL), were within normal ranges. A
complete systemic evaluation revealed no evidence of
other disease.
The patient underwent Simpson grade I resection via the
left frontotemporal approach followed by cranioplasty with
bone cement. Craniotomy exposed a soft, mildly vascular
tumor invading the subcutaneous layers of the scalp, skull
bone, and cerebral parenchyma (Fig. 2). No new neurologic
deficits developed after the surgery.
Pathologic examination revealed atypical meningioma
(World Health Organization [WHO] grade II) (Fig. 3). The
patient was discharged from the hospital on postoperative
day 15. Three weeks after surgery, adjuvant fractionated
conformal radiotherapy was initiated (dose, 5400 cGy
in 30 fractions), covering the entire tumor bed. The
patient is currently undergoing regular follow-up at theea (arrow). (B) Intraoperative finding of a well-defined, soft
ad). (C) Intraoperative finding of brain invasion (arrow) after
excision.
Figure 3 Pathologic finding: atypical meningioma with
meningothelial cells in solid sheets, with increased mitotic
activity (more than 4 mitoses/10 per high-power field, arrow)
and areas of geographic necrosis (original magnification (A)
hematoxylin and eosin stain, 400 and (B) hematoxylin and
eosin stain, 100).
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observed.3. Discussion
In adults, the differential diagnosis of osteolytic skull
lesions depends on the patient’s age, clinical presentation,
and imaging study. Metastasis is usually the first impression
if the patient is older than 40 years. However, primary bone
tumors should also be considered.1
Most meningiomas are thought to be primary intradural
lesions and located in the subdural space. Extradural
meningiomas arising in locations other than the dura mater,
such as the skin, nasopharynx, or neck, also have been
reported.4 A meningioma originating at an extradural
location was first reported in 1904 by Winkler.2 The inci-
dence of primary extradural meningiomas is approximately
1e2% of all meningiomas.5
Primary intraosseous meningioma is a term used to
describe a subset of extradural meningiomas that arise in
bone.6 This type of meningioma approximately accounts for
two-thirds of all extradural meningiomas.4 Even when
intraosseous meningiomas invade the dura mater and/orbrain parenchyma, some authors insist on using the term
”intraosseous meningioma” or “primary extradural menin-
gioma”.7 Other authors, however, would say that dural
invasion precludes a diagnosis of intraosseous menin-
gioma.8 In our case, the main part of the tumor was located
in the skull, so we considered that this tumor was primarily
an intraosseous meningioma.
Convexity intraosseous meningiomas most commonly
present as slowly growing scalp masses, with possible
relationship to a cranial suture. Intraosseous meningiomas
are mostly characterized by osteoblastic or mixed osteo-
blasticeosteolytic lesions, with purely lytic lesions being
the least reported in intraosseous meningiomas. Recent
studies indicate that intraosseous meningiomas have
a higher incidence of malignant features than intradural
meningiomas.5 Wide surgical excision for an intraosseous
meningioma is the treatment of choice and is potentially
curative if the surgery is possible.9 Cranial reconstruction
should be performed at the same time. Although most of
such tumors are histologically benign, they may encroach
on or involve certain parts of the skull that render the
lesion not completely resectable. In 26% of these tumors
there may be evidence of atypical or malignant changes.
Adjuvant therapy in accordance with clinical findings may
include radiation therapy, chemotherapy, and bisphospho-
nate therapy.5 Because most tumors are slow growing, long-
term follow-up is required. Recurrence of atypical or
malignant intraosseous meningiomas has been reported to
occur up to 2 years after resection, whereas histologically
benign tumors have been reported to recur up to 10 years
after surgery.4 In 2004, Rosahl et al.3 reported 16 cases of
primary intraosseous osteolytic meningiomas without
evidence of soft-tissue invasion. We report a rare case of an
atypical osteolytic intraosseous meningioma (WHO grade II)
with soft-tissue and brain invasion in a 68-year-old woman.
An atypical meningioma is a malignant tumor. Early
administration of fractionated radiation therapy to patients
who had undergone both subtotal and total resections
resulted in favorable outcomes.10 Our patient underwent
Simpson grade I resection followed by adjuvant radio-
therapy (dose, 5400 cGy with 30 fractions), and the result
so far has been satisfactory.
In summary, we emphasize that atypical intraosseous
meningioma must be considered in the differential diag-
nosis of osteolytic skull tumors, and combined surgical
interventions and adjuvant radiotherapy are required in
older patients with atypical intraosseous meningiomas.References
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